ICRA has upgraded the outlook for IBM India Private Limited from 'Negative' to 'Stable' following robust 2025 earnings and a major US Defense contract. Analysts maintain a 'Moderate Buy' consensus with a $319.67 target, even as the stock closed down -0.86% at $296.36 on February 9.

  • IBM reported strong 2025 results with full-year revenue up 6% and a ten-year high free cash flow of $14.7 billion.
  • The company secured a significant $151 billion ceiling contract for the US Defense Missile Defense Agency's SHIELD program.
  • While the stock has faced cautious sentiment recently, it traded slightly higher in after-hours at $296.50 (+0.05%).